Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

Fauci vs Kardashian: the public prefers health tips from experts

Written by | 11 Mar 2021

Article written by Gary Finnegan. People are more willing to reshare calls for social distancing if the message is endorsed by a well-known expert – such as US… read more.

COVID lockdown hits air ambulance services in remote Australia

Written by | 10 Mar 2021

Article written by Gary Finnegan. New data released by Australian researchers reveals the impact of the COVID-19 lockdown period on aeromedical retrievals in rural and remote regions. Researchers… read more.

Face masks reduced spread of COVID-19 during first wave

Written by | 9 Mar 2021

Article written by Gary Finnegan. Face masks likely played a role in reducing the spread of SARS-CoV-2 in Italy during the first half of 2020, according to a… read more.

Phase III study of Covaxin reports efficacy of 80.6% in COVID-19 – Ocugen/Bharat Biotech

Written by | 8 Mar 2021

Ocugen announced that its co-development partner, Bharat Biotech, announced the results of the first interim analysis of its Phase III study of Covaxin, a whole virion inactivated COVID-19… read more.

Drug treatment for the systemic inflammatory response in covid-19

Written by | 3 Mar 2021

Interview and article by Christine Clark Dr Mark Tomlin, consultant critical care pharmacist, describes how recent trial findings have identified effective treatments for the systemic inflammatory response syndrome… read more.

Understanding the systemic inflammatory response in covid-19

Written by | 2 Mar 2021

Interview and article by Christine Clark Although SARS-CoV-2 causes a mild illness in many people, some experience severe illness characterised by a systemic inflammatory response that can lead… read more.

Pfizer and BioNTech SE initiate a study as part of broad development plan to evaluate COVID 19 booster and new vaccine variants

Written by | 1 Mar 2021

Pfizer Inc.and BioNTech SE announced they have begun an evaluation of the safety and immunogenicity of a third dose of the Pfizer-BioNTech COVID-19 vaccine (BNT162b2) to understand the… read more.

Vaccination potential will not be achieved without increased production, affordable pricing, global availability, and successful rollout

Written by | 26 Feb 2021

To ensure an effective global immunisation strategy against COVID-19, vaccines need to be produced at scale, priced affordably, and allocated globally so that they are available where needed,… read more.

Health Canada approves Assure Tech Ecotest COVID-19 serological rapid test for COVID-19 – Verify Diagnostics

Written by | 26 Feb 2021

Verify Diagnostics announced that Health Canada has authorized the Assure Tech Ecotest COVID-19 serological rapid test to be used at the point-of-care (POC) for the purpose of screening… read more.

Pfizer and BioNTech submit COVID-19 vaccine stability data at standard freezer temperature to the FDA

Written by | 23 Feb 2021

Pfizer Inc. and BioNTech SE announced the submission of new data to the FDA demonstrating the stability of their COVID-19 vaccine when stored at -25°C to -15°C (-13°F… read more.

Putting the SHAPES pilot project into action

Written by | 23 Feb 2021

Interview and article by Christine Clark Dr Maureen Spargo and Dr Nicola Goodfellow describe how SHAPES, a pan-European digital healthcare project is being put into action in Northern… read more.

WHO gives COVID-19 Vaccine AstraZeneca Emergency Use Listing for COVID-19 – AstraZeneca

Written by | 21 Feb 2021

AstraZeneca’s COVID-19 vaccine has been granted Emergency Use Listing (EUL) by the World Health Organization (WHO) for active immunisation to prevent COVID-19 in individuals 18 years of age… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.